PDL BioPharma Inc (NASDAQ:PDLI)

2.91
Delayed Data
As of 4:00pm ET
 -0.02 / -0.68%
Today’s Change
2.05
Today|||52-Week Range
3.55
+6.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
AssetsCash314.3M349.4M510.1M527.3M
 
 
 
 
 
Short Term Investment Cash167.2M35.1M160.7M17.2M
 
 
 
 
 
Cash & Short Term Investments409.3M435.3M516.5M532.1M
 
 
 
 
 
 
ReceivablesReceivables125.3M83.2M75.0M84.8M
 
 
 
 
 
 
InventoriesInventories3.5M11.5M12.2M9.1M
 
 
 
 
 
 
Current AssetsOther Current Assets5.9M6.9M9.5M14.4M
 
 
 
 
 
Current Assets544.0M536.8M613.2M640.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross------18.7M
 
 
Depreciation-------11.5M
 
 
Intangible Assets516.3M571.3M574.0M565.0M
 
 
 
 
 
Other Assets523.8M573.1M575.2M569.3M
 
 
 
 
 
Total Assets1.2B1.3B1.2B1.2B
 
 
 
 
 
 
LiabilitiesAccounts Payable18.0M10.4M10.4M19.8M
 
 
 
 
 
Short Term Debt122.7M123.8M124.9M126.1M
 
 
 
 
 
Accrued Expenses30.2M25.3M23.7M27.6M
 
 
 
 
 
Other Current Liabilities121.0M119.9M43.2M39.8M
 
 
 
 
 
Other Liabilities275.3M276.3M194.1M193.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt112.4M114.0M115.7M117.4M
 
 
 
 
 
Deferred Taxes-11.7M-18.2M-6.2M-1.2M
 
 
 
 
 
Other Liabilities13.6M14.9M15.5M54.8M
 
 
 
 
 
Total Liabilities474.8M483.2M400.9M397.2M
 
 
 
 
 
 
EquityMinority Interest-47.0K0.000.000.00
 
 
Preferred Stock0.000.000.000.00--
Common Equity758.7M818.8M823.0M845.9M
 
 
 
 
 
Total Shareholder Equity758.7M818.8M823.0M845.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding163.7M154.1M154.3M153.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.